This antibody impeded HMGB1-mediated TLR4-dependent biological effects in vitro and exerted beneficial therapeutic effects in a preclinical model of Alzheimer ́s disease [91]. Here, TLR4 is linked to early-onset autosomal dominant Alzheimer disease.